Vaginal microbicides: moving ahead after an unexpected setback.
van de Wijgert
Janneke Hhm
JH
Shattock
Robin J
RJ
D000282:Administration, Intravaginal; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D002482:Cellulose / Q000009:adverse effects / Q000031:analogs & derivatives; D002986:Clinical Trials as Topic; D004198:Disease Susceptibility; D005260:Female; D015658:HIV Infections / Q000209:etiology / Q000517:prevention & control* / Q000635:transmission; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D014621:Vagina / Q000187:drug effects; D014622:Vaginal Creams, Foams, and Jellies
D019380:Anti-HIV Agents; D014622:Vaginal Creams, Foams, and Jellies; D002482:Cellulose; C020254:cellulose sulfate